Now Reading: Haemophilia treatment advances, early access still poor in India
-
01
Haemophilia treatment advances, early access still poor in India
Treatment for haemophilia has become simpler and more effective, with prescription medicines and gene therapy now available. However, the Deccan Herald reports that many patients in India remain undiagnosed or undertreated, highlighting…
The Story in Brief
Treatment for haemophilia has become simpler and more effective, with prescription medicines and gene therapy now available. However, the Deccan Herald reports that many patients in India remain undiagnosed or undertreated, highlighting the need for better diagnostic facilities across the country. Early access to care can prevent long-term joint damage and improve quality of life, but gaps in awareness and infrastructure persist.
The Indian Opinion
Stories about gene therapy and simpler drugs create a false sense that haemophilia is now easy to manage in India. The real story is the diagnostic desert: most patients are male children, but thousands never see a doctor until irreversible joint damage sets in. The test that matters is how many new patients are diagnosed each year versus the estimated lakhs still hidden. Until hospitals in tier-2 towns offer clotting factor assays routinely, headlines about medical progress mean little.
Source: deccanherald.com
This story was synthesised by AI from the source linked above.
